Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 25, 2023

SELL
$33.32 - $40.98 $88,131 - $108,392
-2,645 Reduced 16.25%
13,631 $485,000
Q4 2022

Jan 26, 2023

BUY
$25.32 - $51.45 $209,523 - $425,748
8,275 Added 103.42%
16,276 $0
Q3 2022

Nov 09, 2022

BUY
$46.5 - $79.14 $83,002 - $141,264
1,785 Added 28.72%
8,001 $377,000
Q2 2022

Aug 05, 2022

BUY
$63.06 - $84.75 $100,517 - $135,091
1,594 Added 34.49%
6,216 $446,000
Q1 2022

May 09, 2022

BUY
$74.15 - $99.36 $87,052 - $116,648
1,174 Added 34.05%
4,622 $374,000
Q4 2021

Mar 21, 2022

SELL
$86.01 - $102.89 $10,923 - $13,067
-127 Reduced 3.55%
3,448 $354,000
Q3 2021

Mar 21, 2022

BUY
$84.7 - $96.31 $53,869 - $61,253
636 Added 21.64%
3,575 $313,000
Q2 2021

Mar 21, 2022

BUY
$76.44 - $89.57 $224,657 - $263,246
2,939 New
2,939 $263,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Humankind Investments LLC Portfolio

Follow Humankind Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.